FAIM
RGEN icon

Financial Advocates Investment Management’s Repligen RGEN Stock Holding History

Financial Advocates Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,823
Closed -$364K – 842
2022
Q3 		$364K Buy
+6,823
New +$1.44M 0.03% 499

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Financial Advocates Investment Management's RGEN Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 6,823 shares — an estimated $364K sold.

Financial Advocates Investment Management first reported a position in RGEN in Q3 2022 and held it in 1 quarter. The position peaked at $364K in Q3 2022. 443 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 6,823 Repligen shares in Q4 2022, an estimated $364K.
  • Financial Advocates Investment Management first reported a position in Repligen in Q3 2022 and held it in 1 quarter.
  • Financial Advocates Investment Management's Repligen position peaked at $364K in Q3 2022.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.